Share-based Payment Arrangement, Expense of Achilles Therapeutics plc from 31 Dec 2019 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Achilles Therapeutics plc quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2019 to 30 Jun 2024.
  • Achilles Therapeutics plc Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $1,312,000, a 23% decline year-over-year.
  • Achilles Therapeutics plc annual Share-based Payment Arrangement, Expense for 2023 was $6,357,000, a 9.5% decline from 2022.
  • Achilles Therapeutics plc annual Share-based Payment Arrangement, Expense for 2022 was $7,022,000, a 11% increase from 2021.
  • Achilles Therapeutics plc annual Share-based Payment Arrangement, Expense for 2021 was $6,317,000, a 111% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Achilles Therapeutics plc Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $1,312,000 -$389,000 -23% 01 Apr 2024 30 Jun 2024 6-K 14 Aug 2024 2024 Q2
Q2 2023 $1,701,000 -$23,000 -1.3% 01 Apr 2023 30 Jun 2023 6-K 14 Aug 2024 2024 Q2
Q2 2022 $1,724,000 01 Apr 2022 30 Jun 2022 6-K 04 Aug 2023

Achilles Therapeutics plc Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $6,357,000 -$665,000 -9.5% 01 Jan 2023 31 Dec 2023 20-F 04 Apr 2024 2023 FY
2022 $7,022,000 +$705,000 +11% 01 Jan 2022 31 Dec 2022 20-F 04 Apr 2024 2023 FY
2021 $6,317,000 +$3,325,000 +111% 01 Jan 2021 31 Dec 2021 20-F 04 Apr 2024 2023 FY
2020 $2,992,000 +$2,273,000 +316% 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023 2022 FY
2019 $719,000 01 Jan 2019 31 Dec 2019 20-F 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.